With annual CPhI events being a big part of the pharma calendar, the industry will no doubt be relieved to see the announcement of rescheduled dates, rather than cancellations.

CPhI has worked quickly to secure new dates for a handful of its 2020 events, and so far has confirmed new exhibition dates for CPhI Japan, CPhI South East Asia and CPhI North America;  it’s further announced that it is proactively looking into more digital content options for its audience which is likely to be much appreciated in these tough times.

Read the full announcement here and be sure to also check out the QUINTA-ANALYTICA blog post which covers not only CPhI, but also other pharma events which are cancelled or rescheduled in the coming months.

Additional News

  • 17 December 2025

    PF 2026: Thank You from Quinta-Analytica

    In 2025, Quinta-Analytica continued to turn complex development challenges into tangible progress. Our PF 2026 message looks back at key milestones and thanks the partners, clients, and teams who made them possible.

  • 15 December 2025

    IVBE for locally acting drugs: insights from Conscio Science Day in Munich

    Can bioequivalence for locally acting drugs be demonstrated without a single subject in a clinical trial? Yes, if your in vitro bioequivalence (IVBE) toolkit is set up in the right way.

  • 20 November 2025

    Webinar: Streamlined Evidence Strategies for Biosimilars: Analytics, PK and Immunogenicity in focus

    On behalf of Conscio Group, we are pleased to invite you to the upcoming free educational webinar from biosimilar series.